Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02261597 · ClinicalTrials.gov registry record
Challenging the Inflammatory Response System in Insomnia Disorder
A clinical trial of Insomnia, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 44
- Enrollment target
- 1
- Study location
NCT02261597: Completed study of Insomnia, sponsored by Beth Israel Deaconess Medical Center.
NCT02261597 is a study of Insomnia that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 44 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02261597, a study of Insomnia, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to understand how insomnia (compared to good sleep) may affect the response of the body to a repeated physiological challenge, such as inserting the hand in ice-cold water for several times in a row. In particular, the investigators are interested in the response of markers that can be associated with stress, such as blood pressure and stress hormones.
Primary Outcome
Inflammatory marker: Change in plasma levels of IL-6 (pg/mL).
Conditions Studied
Interventions
- BEHAVIORAL Cold Pressor Test
Study Locations (1)
Massachusetts
- BIDMC - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-03 |
What the finished NCT02261597 record still lists
NCT02261597 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Cold Pressor Test is the first listed.
NCT02261597 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02261597 about?
NCT02261597 is a clinical study titled "Challenging the Inflammatory Response System in Insomnia Disorder". The main purpose of this study is to understand how insomnia (compared to good sleep) may affect the response of the body to a repeated physiological challenge, such as inserting the hand in ice-cold water for several times in a row. In particular, the investigators are interested in the response of...
What is the current status of trial NCT02261597?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2015-01. Estimated completion is 2018-03.
What conditions does trial NCT02261597 study?
This clinical trial studies the following conditions: Insomnia.
What interventions are being tested in trial NCT02261597?
The interventions under investigation include: Cold Pressor Test (BEHAVIORAL).
Who is sponsoring clinical trial NCT02261597?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02261597 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02261597's enrollment target sits among peer trials
44 111th of 151 higher than 40 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
RECRUITING
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Pimavanserin for Insomnia in Veterans With PTSD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia